APA (7th ed.) Citation

Manolis, E., Musuamba, F. T., de Vries, C. S., Colin, P. J., & Oleksiewicz, M. B. (2024). EMA perspective on the value of model‐informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding. CPT: Pharmacometrics & Systems Pharmacology, 13(11), 1820. https://doi.org/10.1002/psp4.13214

Chicago Style (17th ed.) Citation

Manolis, Efthymios, Flora Tshinanu Musuamba, Corinne S. de Vries, Pieter J. Colin, and Martin B. Oleksiewicz. "EMA Perspective on the Value of Model‐informed Drug Development for Labeling Recommendations Regarding Medicine Use During Pregnancy and Breastfeeding." CPT: Pharmacometrics & Systems Pharmacology 13, no. 11 (2024): 1820. https://doi.org/10.1002/psp4.13214.

MLA (9th ed.) Citation

Manolis, Efthymios, et al. "EMA Perspective on the Value of Model‐informed Drug Development for Labeling Recommendations Regarding Medicine Use During Pregnancy and Breastfeeding." CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 11, 2024, p. 1820, https://doi.org/10.1002/psp4.13214.